A Systematic Review of Pharmacoeconomic Evaluation of Erlotinib in The First-Line Treatment of Advanced Non-Small Cell Lung Cancer
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.230
https://www.valueinhealthjournal.com/article/S1098-3015(17)30564-8/fulltext
Title :
A Systematic Review of Pharmacoeconomic Evaluation of Erlotinib in The First-Line Treatment of Advanced Non-Small Cell Lung Cancer
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30564-8&doi=10.1016/j.jval.2017.08.230
First page :
A438
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
209